VIVEbiotech to Exhibit at Advanced Therapies Europe 2025 in Barcelona
Visit us at booth no. 26 from September 2–4 and discover our lentiviral vector services for advanced therapies.
VIVEbiotech is excited to attend Advanced Therapies Europe 2025, organized by Phacilitate, taking place from September 2–4 at the Hotel Arts in Barcelona.
You can find us at booth no. 26, where our team will showcase our expertise in the manufacturing of lentiviral vectors for advanced therapies, with a growing focus on in-vivo applications.
Representing VIVEbiotech:
- Patricio Massera, President & Board Member
- Natalia Elizalde, Chief Business Development Officer
- Víctor Martínez Polo, Business Development Manager
At VIVEbiotech, we specialize in delivering high-quality, cost-effective, and innovative lentiviral vector services to support gene and cell therapy programs around the world.
All three representatives are already active on the partnering platform GRIP — feel free to connect and schedule a meeting in advance.
Let’s talk science — and curing patients through advanced therapies.